Products: Regenity’s technology platforms span collagen (extracellular matrix, gelatin, soluble, reconstituted, coatings and films), bioceramics, synthetic polymers (co-polymers, polyurethanes, fumarates, thermoplastics, tissue adhesives), specialty metals, and bioactive agents including hyaluronic acid, chitosan, and growth factors. Orthopedics, Spine & Sports Medicine — xenograft mineral and collagen composite bone graft substitutes, TenoMend resorbable collagen tendon wraps, and RejuvaKnee, a minimally invasive collagen meniscal repair implant that received 510(k) clearance in October 2024.